Archive for December 2006
Accurate Interpretation of the Visual Predictive Check in order to Evaluate Model Performance
Post T.M., Freijer J.I., Winter W.d., Danhof M. and Ploeger B., Accurate Interpretation of the Visual Predictive Check in order to Evaluate Model Performance. PAGE.(2006). [Link to publication]
Read MoreDisease system analysis distinguishing disease status from disease process
Jongh J.d., Post T., Freijer J., Winter W.d., Danhof M. and Ploeger B., Disease system analysis distinguishing disease status from disease process. Noordwijkerhout.(2006).
Read MorePropofol pharmacokinetics and pharmacodynamics for depth of sedation
Peeters M.Y., Prins S.A., Knibbe C.A., Jongh J.d., Schaik R.H.v., Dijk M.v., Heiden I.P.v.d., Tibboel D. and Danhof M., Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery, Anesthesiology, 104(3): 466-474, 2006. [Link to publication]
Read MorePharmacokinetics and pharmacodynamics of midazolam and metabolites
Peeters M.Y., Prins S.A., Knibbe C.A., Jongh J.d., Mathot R.A., Warris C., Schaik R.H.v., Tibboel D. and Danhof M., Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery, Anesthesiology., 105(6): 1135-1146., 2006. [Link to publication]
Read MorePopulation pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients
Swart E.L., Zuideveld K.P., Jongh J.d., Danhof M., Thijs L.G. and Strack van Schijndel R.M., Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients, Eur J Clin Pharmacol., 62(3): 185-194., 2006. [Link to publication]
Read MoreLong-term effects of pioglitazone, metformin and gliclazide
Winter W.d., Jongh J.d, Post T., Ploeger B., Urquhart R., Moules I., Eckland D. and Danhof M., A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus, J Pharmacokinet Pharmacodyn., 33(3): 313-343., 2006. [Link to publication]
Read More